Acute Coronary Syndrome
1,025
92
124
569
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
103 trials with published results (10%)
Research Maturity
569 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.5%
56 terminated out of 1025 trials
91.0%
+4.5% vs benchmark
23%
232 trials in Phase 3/4
18%
103 of 569 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 569 completed trials
Clinical Trials (1025)
Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Polymer-free Sirolimus Eluting Stent: Real-world Investigation of Safety and Outcomes
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE)
Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
A Genomic Approach for Clopidogrel in Caribbean Hispanics
Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
MT1002 Phase II Study in ACS Patients With PCI
Acute Coronary Syndrome and Acupressure
Feasibility Study of a Digital Interactive Life-style Platform for Individuals After Rehabilitation
Polypill in Acute Coronary Syndrome
Florbetaben for Imaging of Vascular Amyloid
The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention
Point of Care Evaluation of High-sensitivity Cardiac Troponin
Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia
Evolocumab in Acute Coronary Syndrome